Biotech Values

[DewDiligence]

Roche-DNA Survey, Part Deux

For background info, please see #msg-35219504 and #msg-35253757.


Q: Which of the following is the most like outcome?

a) Roche’s tender fails to obtain enough shares to continue with a merger, Roche withdraws the offer, and the companies return to business as usual.

b) Roche’s tender obtains enough shares to force a shareholder vote, shareholders vote in favor of the $86.50 price, and a ‘hostile’ merger is consummated at $86.50.

c) Roche’s tender obtains enough shares to force a shareholder vote, but DNA and Roche agree to a ‘friendly’ merger at a price higher than $86.50.

d) Some other outcome.


To vote, please go to
http://investorshub.advfn.com/boards/board_surveymenu.asp?board_id=1418
and select survey #120.